1. Home
  2. FORM vs CLDX Comparison

FORM vs CLDX Comparison

Compare FORM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

HOLD

Current Price

$55.30

Market Cap

4.5B

Sector

Technology

ML Signal

HOLD

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$27.36

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORM
CLDX
Founded
1993
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
1.9B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
FORM
CLDX
Price
$55.30
$27.36
Analyst Decision
Buy
Buy
Analyst Count
9
10
Target Price
$55.75
$43.80
AVG Volume (30 Days)
654.7K
775.5K
Earning Date
10-29-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.53
N/A
Revenue
$759,313,000.00
$2,599,000.00
Revenue This Year
$3.97
N/A
Revenue Next Year
$10.24
$19.70
P/E Ratio
$104.87
N/A
Revenue Growth
2.29
N/A
52 Week Low
$22.58
$14.40
52 Week High
$61.10
$30.50

Technical Indicators

Market Signals
Indicator
FORM
CLDX
Relative Strength Index (RSI) 55.44 52.62
Support Level $56.88 $27.51
Resistance Level $60.30 $28.79
Average True Range (ATR) 1.99 1.34
MACD -0.10 0.04
Stochastic Oscillator 53.80 43.25

Price Performance

Historical Comparison
FORM
CLDX

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: